Gene and Cell Therapy – Multimedia

A major challenge preventing transformative gene therapies from reaching patients is the lack of fit-for purpose potency assays, which are some of the most important assays in an analytical package but are often the most complex and high-risk.

Hear from three Simple Western users on why they use our next-generation, automated, western blot systems for cell and gene therapy workflows. Simple Western is a gel-free, blot-free, hands-free capillary western blot analysis.

Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.

CAR-T cell therapy has emerged as one of the most promising novel treatments in the fight against cancer.

Interest in CGT&RMs has grown alongside the pharmaceutical and biotechnology industries in recent years; Japan’s established, rapidly expanding market makes it the perfect location to facilitate successful CGT&RM programs. `

Metabolism is a key driver of CAR-T cell fitness and function. Hence, metabolic preconditioning methods can enhance the bioenergetic capacity of CAR-T cells in culture, supporting their persistence and antitumor activity

In this informative video, you will discover the latest technologies and workflows used in the field of cell and gene therapy.

Adeno-associated viruses (AAVs) are considered one of the most effective and safe ways to deliver therapeutic genes for the treatment of a wide range of genetic conditions.

Metabolism has emerged as a key driver of T-cell antitumor function. This means that modulating metabolic programs of T cells can be used as a strategy to improve the antitumor efficacy of adoptive T-cell therapies.

The scale of research into potential gene therapies often means that work is distributed across multiple locations. Investigators must have confidence that the results obtained at one site are consistent with results obtained at other sites participating in the study.